EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough sarcomas in young patients
Disease control CompletedThis study tested whether a combination of two chemotherapy drugs, nab-paclitaxel and gemcitabine, can stop or slow tumor growth in teenagers and young adults (ages 3 to 30) whose sarcoma (a type of bone or soft tissue cancer) had returned or was not responding to standard treatm…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Promising drug combo targets tough bone cancer
Disease control CompletedThis study tested a combination of two drugs, trabectedin and irinotecan, in 37 people with a type of bone cancer called Ewing sarcoma that had come back or not responded to other treatments. The goal was to find the safest dose and see if the drugs could shrink tumors. Participa…
Matched conditions: EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
Experimental drug cocktail targets tough childhood cancers in adults
Disease control CompletedThis early-phase study tested a combination of two drugs, olaparib and temozolomide, in 49 adults with Ewing sarcoma or rhabdomyosarcoma that had come back or spread after standard chemotherapy. The goal was to find the safest dose and see if the combo could shrink tumors. While …
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New stem cell approach offers hope for kids with relapsed cancers
Disease control CompletedThis study tested a new type of stem cell transplant for children and young adults (ages 2-21) with cancers that came back or didn't respond to treatment. The approach uses a special cell filter to speed up immune recovery after transplant. The main goal was to see if the procedu…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
AI sifts through 700 bone cancer records to uncover survival clues
Knowledge-focused CompletedThis study looked at the medical records of 700 people diagnosed with osteosarcoma or Ewing's sarcoma between 2003 and 2012. Researchers used computer programs and machine learning to find patterns in the data, especially around survival. No new treatments were given or tested.
Matched conditions: EWING SARCOMA
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC